Manas AI

Manas AI is an artificial-intelligence drug-discovery company co-founded by Reid Hoffman and physician-scientist Siddhartha Mukherjee, launched in late 2024 and backed by General Catalyst and Greylock. The company applies machine learning and computational biology to accelerate the discovery and design of new medicines, with an initial focus on hard-to-treat cancers such as breast and prostate cancer and lymphoma. Manas AI operates as a private biotech / therapeutics research organization rather than a developer-facing platform: as of this profile it publishes no public API, developer portal, SDKs, or technical documentation. This entry is maintained in the API Evangelist network as a company profile surfaced from the General Catalyst portfolio.

Manas AI is profiled on the APIs.io network. Tagged areas include Company, Artificial Intelligence, Drug Discovery, Biotechnology, and Healthcare.

🌐 Visit website 📡 Source on GitHub
2.2/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-20 · rubric v0.12.0
0 APIs
CompanyArtificial IntelligenceDrug DiscoveryBiotechnologyHealthcareMachine-LearningOncologyLife Sciences

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-08-20 · rubric v0.12.0
Composite quality — 2.2/100 · minimal
Contract Quality 0.0 / 21
Developer Ergonomics 0.0 / 17
Access Clarity 0.0 / 17
Operational Transparency 0.0 / 11
Contract Governance 0.0 / 10
Discoverability 4.3 / 9
Regulatory Posture 0.0 / 15
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 10
Documented Reversibility 0 / 6
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
A2A Agent Card 0 / 8
Dry-Run / Simulate Mode 0 / 4
Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.
The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/manas-ai: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Source (apis.yml)

apis.yml Raw ↑ 
aid: manas-ai
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/manas-ai.png
name: Manas AI
description: 'Manas AI is an artificial-intelligence drug-discovery company co-founded by Reid Hoffman and physician-scientist
  Siddhartha Mukherjee, launched in late 2024 and backed by General Catalyst and Greylock. The company applies machine learning
  and computational biology to accelerate the discovery and design of new medicines, with an initial focus on hard-to-treat
  cancers such as breast and prostate cancer and lymphoma. Manas AI operates as a private biotech / therapeutics research
  organization rather than a developer-facing platform: as of this profile it publishes no public API, developer portal, SDKs,
  or technical documentation. This entry is maintained in the API Evangelist network as a company profile surfaced from the
  General Catalyst portfolio.'
url: https://raw.githubusercontent.com/api-evangelist/manas-ai/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- general-catalyst
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.23'
created: '2026-07-17'
modified: '2026-07-20'
tags:
- Company
- Artificial Intelligence
- Drug Discovery
- Biotechnology
- Healthcare
- Machine-Learning
- Oncology
- Life Sciences
tags_raw:
- Company
- Artificial Intelligence
- Drug Discovery
- Biotechnology
- Healthcare
- Machine Learning
- Oncology
- Life Sciences
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-20'
  status: minimal
  artifacts_added: 0
  pass: local-v1